Daftar Isi:
  • Background: Dysmenorrhea is Dysmenorrhea is a common complaint in young women. Dysmenorrhea in various levels can cause mild to severe effects that can interfere with daily activities. Patients tend to seek treatment to eliminate dysmenorrhoea complaints. Non-steroidal anti-inflammatory drugs (NSAIDS) are the main treatment of dysmenorrhea. NSAIDs have been shown to effectively inhibit cyclooxygenase enzymes that lead to a decrease in prostaglandin production, thus reducing discomfort in dysmenorrhea. This study was conducted to determine the prevalence of NSAID as a dysmenorrhoea in Faculty of Medicine Sriwijaya University Palembang force 2014-2016. Methods: The type of research used is descriptive observational with cross sectional design. The population of this research is all female students of Medical Faculty of Sriwijaya University class of 2014-2016 who have dysmenorrhea. The samples were taken using total sampling technique. The data are described to know the prevalence of NSAID use as a dysmenorrhea reliever in the Faculty of Medicine Sriwijaya University Palembang class of 2014-2016. Results: There were 244 respondents who met the inclusion criteria, consisting of age 20 and age ≥ 21 years old in 87 people (35.7%), age ≤ 19 years 70 persons (28.7%). The prevalence of NSAID use was 53.7% (131 respondents) with minimal side effects (4.6%) in the form of epigastric pain. The distribution of NSAID types was as follows: mefenamic acid (74.8%), ibuprofen (18.3%), acetaminophen (6.1%), and natrium diclofenac (0.8%). Conclusion: Use of NSAIDs is the main treatment option (53.7%) as a dysmenorrhea reliever with minimal side effects.